Biology and pathophysiology of tissue factor and its relevance to cardiovascular pathology;Biologia e fisiopatologia del fattore tissutale e sua rilevanza per la patologia cardiovascolare

Italian Heart Journal, Supplementi

Volumn 4, Issue 7, 2003, Pages 559-568

  Del Turco, Serena ^a,b   De Caterina, Raffaele ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Acute coronary syndromes; Atherosclerosis; Thrombosis

Indexed keywords

ANTI COAGULANT PROTEIN C2, ANCYLOSTOMA CANINUM; ANTI-COAGULANT PROTEIN C2, ANCYLOSTOMA CANINUM; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9; FIBRINOLYTIC AGENT; HELMINTH PROTEIN; THROMBOPLASTIN;

ANIMAL; ARTERIOSCLEROSIS; BLOOD; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; HEART INFARCTION; HEMOSTASIS; HUMAN; PHYSIOLOGY; REVIEW; SYNDROME; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANIMALS; ARTERIOSCLEROSIS; BLOOD COAGULATION; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FACTOR IX; FACTOR VII; FACTOR VIIA; FACTOR X; FIBRINOLYTIC AGENTS; HELMINTH PROTEINS; HEMOSTASIS; HUMANS; MYOCARDIAL INFARCTION; SYNDROME; THROMBOPLASTIN; THROMBOSIS;

EID: 77957115744     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79.
2. Fuster V, Fallon JT, Badimon JJ, Nemerson Y. The unstable atherosclerotic plaque: clinical significance and therapeutic intervention. Thromb Haemost 1997; 78: 247-55. (Pubitemid 27289249)
3. Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000; 10: 139-43. (Pubitemid 32178189)
4. Petersen LC, Freskgard P, Ezban M. Tissue-factor-dependent factor VIIa signaling. Trends Cardiovasc Med 2000; 10: 47-52.
5. Harlos K, Martin DMA, O'Brien DP, et al. Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370: 662-6.
6. Muller YA, Ultsch MH, Kelley RF, de Vos AM. Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry 1994; 33: 10864-70.
7. Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41. (Pubitemid 26027721)
8. Morrissey JH, Neuenschwander PF, Huang Q, McCallum CD, Johnson AE. Factor VIIa-tissue factor: functional importance of protein-membrane interactions. Thromb Haemost 1997; 78: 112-6. (Pubitemid 27289226)
9. Banner DW, D'Arcy A, Chene C, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380: 41-6.
10. Hoffman M, Monroe DM, Oliver JA, Roberts HR. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995; 86: 1794-801.
11. Rapaport SI, Rao LV. The tissue factor pathway: how it has become a "prima ballerina". Thromb Haemost 1995; 74: 7-17.
12. Sandset PM. Tissue factor pathway inhibitor (TFPI) - an update. Haemostasis 1996; 26: 154-65.
13. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43. (Pubitemid 19112635)
14. Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc Res 2002; 53: 313-25. (Pubitemid 34117681)
15. Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J Pathol 1999; 188: 180-8. (Pubitemid 29253938)
16. Ardissino D, Merlini PA, Arlens R, et al. Tissue factor in human coronary atherosclerotic plaques. Clin Chim Acta 2000; 291: 235-40. (Pubitemid 30089767)
17. Annex BH, Denning SM, Channon KM, et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-22.
18. Lorenzoni R, Gensini GF, De Caterina R. Antithrombotic therapy for unstable angina in non-Q myocardial infarct. G Ital Cardiol 1998; 28: 468-80. (Pubitemid 28182825)
19. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5. (Pubitemid 29117911)
20. Amengual O, Atsumi T, Khamashta MA, Hughes GR. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998; 79: 276-81. (Pubitemid 28065869)
21. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.
22. Soejima H, Ogawa H, Yasue H, et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 1999; 99: 2908-13. (Pubitemid 29258979)
23. Misumi K, Ogawa H, Yasue H, et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol 1998; 81: 22-6. (Pubitemid 28046836)
24. Rauch U, Bonderman D, Bohrmann B, et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96: 170-5. (Pubitemid 30456467)
25. Muller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003; 17: 476-8.
26. Camera M, Brambilla M, Frigerio M, et al. L'attivazione piastrinica induce l'espressione di tissue factor immunoreattivo (irTF) sulla superficie cellulare. (abstr) In: Abstracts Congresso Nazionale della Società Italiana per lo Studio dell'Aterosclerosi. Chieti, 2002: C26.
27. Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombosis disease. Circ Res 2001; 88: 998-1003. (Pubitemid 34137111)
28. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995; 44: 1323-7.
29. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the "response to injury" hypothesis. Circulation 1997; 95: 1760-3.
30. Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 1999; 274: 23111-8. (Pubitemid 129529140)
31. Connolly ES, Winfree CJ, Prestigiacomo CJ, et al. Exarcebation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res 1997; 81: 304-10.
32. x plays an important role in recurrent coronary arterial thrombosis in dogs. Arterioscler Thromb Vasc Biol 1999; 19: 1083-90.
33. Carmeliet P, Mackman M, Moons L, et al. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383: 73-5. (Pubitemid 26296462)
34. Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumour vasculature. Science 1997; 275: 547-50. (Pubitemid 27051913)
35. Randolph GJ, Luther T, Albrecht A, Magdolen V, Muller WA. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 1998; 2: 4167-77. (Pubitemid 28544332)
36. Wiiger MT, Prydz H. Cellular effects of initiation of the extrinsic pathway of blood coagulation. Trends Cardiovasc Med 2000; 10: 360-5. (Pubitemid 32448046)
37. Camerer E, Huang W, Coughlin SR. Tissue factor and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 2000; 97: 5255-60. (Pubitemid 30313705)
38. Peppelenbosh MP, Versteeg HH. Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends Cardiovasc Med 2001; 11: 335-9.
39. Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998; 140: 1241-53. (Pubitemid 28128882)
40. Badimon JJ, Lettino M, Toschi V, et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 1999; 99: 1780-7.
41. Erlich JH, Boyle EM, Labriola J, et al. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 2000; 157: 1849-62.
42. Kelley RF, Refino CJ, O'Connell MP, et al. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent. Blood 1997; 89: 3219-27.
43. Golino P, Ragni M, Cirillo P, et al. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. Circ Res 1998; 82: 39-46.
44. St Pierre J, Yang LY, Tamirisa K, et al. Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs. Arterioscler Thromb Vasc Biol 1999; 19: 2263-8. (Pubitemid 29422261)
45. Abraham E. Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. Crit Care Med 2000; 28 (Suppl): S31-S33.
46. Oltrona L, Speidel CM, Recchia D, Wickline SA, Eisenberg PR, Abendschein DR. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation 1997; 96: 646-52. (Pubitemid 27329446)
47. Zoldhelyi P, Chen ZQ, Shelat HS, McNatt JM, Willerson JT. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci USA 2001; 98: 4078-83. (Pubitemid 32249901)
48. Golino P, Cirillo P, Calabrò P, et al. Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries. J Am Coll Cardiol 2001; 38: 569-76. (Pubitemid 32721790)
49. Rao LV, Ezban M. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action. Blood Coagul Fibrinolysis 2000; 11 (Suppl 1): S135-S143. (Pubitemid 30368718)
50. Golino P, Ragni M, Cirillo P, et al. Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits. Am J Physiol 2000; 278: H1507-H1516.
51. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol 2002; 282: C227-C241. (Pubitemid 34663181)
52. Ambrosio G, Tritto I, Golino P. Reactive oxygen metabolites and arterial thrombosis. Cardiovasc Res 1997; 34: 445-52. (Pubitemid 27272663)
53. Golino P, Ragni M, Cirillo P, et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 1996; 2: 35-40.
54. Rote W, Oldeschulte GL, Dempsey EM, Vlasuk GP. Evaluation of a novel small protein inhibitor of the blood coagulation factor VIIa/tissue complex in animal models of arterial and venous thrombosis. (abstr) Circulation 1996; 94: I-695.
55. Hoppensteadt DA, Walenga JM, Fasanella A, Jeske W, Fareed J. TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin. Thromb Res 1995; 77: 175-85.
56. Abbate R, Gori AM, Modesti PA, et al. Heparin, monocytes, and procoagulant activity. Haemostasis 1990; 20 (Suppl 1): S98-S100.
57. Camera M, Gaviraghi M, Tremoli E. Fluvastatin inhibits TNF-α and LPS-induced c-Rel/p-65 nuclear translocation and tissue factor expression in human endothelial cells. (abstr) Atherosclerosis 1997; 134: 197.
58. Colli S, Eligini S, Lalli M, Camera M, Paoletti R, Tremoli E. Vastatins inhibit tissue factor in human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol 1997; 17: 265-72.
59. Andriamampandry MD, Leray C, Freund M, Cazenave JP, Gachet C. Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis. Thromb Res 1999; 93: 9-16. (Pubitemid 29012755)
60. Thorwest M, Balling E, Kristensen SD, et al. Dietary fish oil reduces microvascular thrombosis in a porcine experimental model. Thromb Res 2000; 99: 203-8.
61. Harker LA, Kelly AB, Hanson SR, et al. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation 1993; 87: 1017-29.
62. Tremoli E, Eligini S, Colli S, et al. n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes. Arterioscler Thromb 1994; 14: 1600-8. (Pubitemid 24312220)
63. Chu AJ, Moore J. Differential effects of unsaturated fatty acids on modulation of endotoxin-induced tissue factor activation in cultured human leukemia U937 cells. Cell Biochem Funct 1991; 9: 231-8.
64. Chu AJ, Walton MA, Prasad JK, Seto A. Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytic tissue factor activation is mediated by the depressed receptor expression in THP-1 cells. J Surg Res 1999; 87: 217-24. (Pubitemid 30000589)
65. Marco J, Ariens RA, Fajadet J, et al. Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris. Am J Cardiol 2000; 85: 527-31.
66. Soejima H, Ogawa H, Yasue H, et al. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. J Am Coll Cardiol 1999; 34: 983-8. (Pubitemid 29500527)